GenVec Reports Fourth Quarter And 2014 Year-End Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
GenVec (GNVC) FY14 Results Flat with Views; Hearing Loss Phase I Update Encouraging - Roth Capital
March 24, 2015 2:12 PM EDTRoth Capital affirms GenVec (Nasdaq: GNVC) at Buy with a price target of $8 following FY14 results.
Analyst Joseph Pantginis noted that GenVec posted FY14 loss of $0.16 per share, which was in-line with the firm's estimate. GenVec also ended FY14 with $14.7 million in cash and that should fund operations through 2017. As... More
GenVec (GNVC) Tops Q4 EPS by 3c
March 24, 2015 7:03 AM EDTGenVec (NASDAQ: GNVC) reported Q4 EPS of $0.11, $0.03 better than the analyst estimate of $0.08. Revenue for the quarter came in at $3.5 million versus the consensus estimate of $3.33 million.
For earnings history and earnings-related data on GenVec (GNVC) click here.
... More